Completed
A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis
NCT03347370
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chemically-Induced Disorders, +11 more
- Locations
-
- Research Site Göttingen, Germany